CD146, a novel target of CD44-signaling, suppresses breast tumor cell invasion

BACKGROUND: We have previously validated three novel CD44-downstream positively regulated transcriptional targets, including Cortactin, Survivin and TGF-β2, and further characterized the players underlying their separate signaling pathways. In the present study, we identified CD146 as a potential no...

Descripción completa

Detalles Bibliográficos
Autores principales: Ouhtit, Allal, Abdraboh, Mohammed E., Hollenbach, Andrew D., Zayed, Hatem, Raj, Madhwa H. G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5679321/
https://www.ncbi.nlm.nih.gov/pubmed/29121955
http://dx.doi.org/10.1186/s12964-017-0200-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5679321/
https://www.ncbi.nlm.nih.gov/pubmed/29121955
http://dx.doi.org/10.1186/s12964-017-0200-3

Ejemplares similares